Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 9/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.46 |
| ▸ | EGFR | P00533 | 2/20 | 0.42 |
| ▸ | F13A1 | P00488 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | TGM1 | P22735 | 1/20 | 0.41 |
| ▸ | TGM3 | Q08188 | 1/20 | 0.41 |
| ▸ | BTK | Q06187 | 1/20 | 0.39 |
| ▸ | GSTO1 | P78417 | 1/20 | 0.39 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.39 |
| ▸ | RORC | P51449 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29954870 | 1.00 | TGM2 (0.52) | TGM2PTPN1PTPN11EGFRF13A1 | |
| SCHEMBL29126030 | 0.87 | MAPT (0.49) | TGM2PTPN1PTPN11LMNABTK | |
| SCHEMBL16634480 | 0.85 | BTK (0.45) | TGM2PTPN1PTPN11F13A1LMNA | |
| SCHEMBL613090 | 0.82 | TGM2 (0.65) | TGM2PTPN1PTPN11EGFRF13A1 | |
| SCHEMBL31228347 | 0.82 | TGM2 (0.65) | TGM2PTPN1PTPN11EGFRF13A1 | |
| SCHEMBL29224775 | 0.81 | GAA (0.40) | TGM2 | |
| SCHEMBL29860424 | 0.81 | MAPT (0.45) | EGFRLMNAKDM4EMAPTPKM | |
| SCHEMBL2249156 | 0.81 | MAPT (0.45) | EGFRLMNAKDM4EMAPTPKM | |
| SCHEMBL28416379 | 0.79 | ALDH1A1 (0.44) | EGFRLMNAKDM4EMAPTPKM | |
| SCHEMBL29204703 | 0.79 | TGM2 (0.45) | TGM2PTPN1PTPN11EGFRF13A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 292 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624204-B2 | Ultra-high molecular weight polymers and methods of using the same | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2026-05-12 | — | — | US | claimed |
| EP-4720728-A1 | COATED SILICONE HYDROGEL CONTACT LENSES AND METHOD FOR MAKING THE SAME | Alcon Inc. (CH) | 2026-04-08 | — | — | EP | claimed |
| WO-2025226869-A1 | GLUCOSE-RESPONSIVE GLUCAGON-MICELLE FOR THE PREVENTION OF HYPOGLYCEMIA AND METHODS OF USE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-10-30 | — | — | WO | claimed |
| EP-3927236-B1 | MEDIATION OF IN VIVO ANALYTE SIGNAL DEGRADATION | SENSEONICS INC (US) | 2025-08-27 | — | — | EP | claimed |
| EP-4599224-A1 | RAPID GELLING AQUEOUS MOUNTING MEDIA | Life Technologies Corporation (US) | 2025-08-13 | — | — | EP | claimed |
| US-12279862-B2 | Mediation of in vivo analyte signal degradation | SENSEONICS, INCORPORATED (US) | 2025-04-22 | — | — | US | claimed |
| EP-4493061-A2 | CATALYTIC REACTIVE OXYGEN SPECIES SCAVENGER HYDROGEL | Senseonics, Incorporated (US) | 2025-01-22 | — | — | EP | claimed |
| CN-118772422-B | Recoverable shape memory composite material with super-strong mechanical property based on polyarylether nitrile and preparation method and application thereof | 西南石油大学 | 2024-11-29 | — | — | CN | claimed |
| WO-2024241239-A1 | COATED SILICONE HYDROGEL CONTACT LENSES AND METHOD FOR MAKING THE SAME | ALCON INC. (CH) | 2024-11-28 | — | — | WO | claimed |
| US-20240393501-A1 | COATED SILICONE HYDROGEL CONTACT LENSES AND METHOD FOR MAKING THE SAME | ALCON INC (CH) | 2024-11-28 | — | — | US | claimed |
| WO-2016142301-A1 | METHOD AND DEVICE FOR DETECTING IN REAL TIME A SECRETED COMPOUND AND THE SECRETION TARGET, AND USES THEREOF | Commissariat à l'énergie atomique et aux énergies alternatives (FR) | 2016-09-15 | — | — | WO | claimed |
| EP-1601999-B1 | Holographic sensor and its use | SMART HOLOGRAMS LTD (GB) | 2013-04-24 | — | — | EP | claimed |
| EP-2464740-A1 | STIMULI RESPONSIVE MEMBRANE | Sensile Pat AG (CH) | 2012-06-20 | — | — | EP | claimed |
| US-20120150006-A1 | STIMULI RESPONSIVE MEMBRANE | SENSILE PAT AG (CH) | 2012-06-14 | — | — | US | claimed |
| WO-2011018752-A1 | STIMULI RESPONSIVE MEMBRANE | SENSILE PAT AG (CH) | 2011-02-17 | — | — | WO | claimed |
| EP-2284275-A1 | Stimuli Responsive Membrane | Sensile Pat AG (CH) | 2011-02-16 | — | — | EP | claimed |
| US-20080214912-A1 | Blood Glucose Monitoring System And Method | GLUCOSE SENSING TECHNOLOGIES, LLC (US) | 2008-09-04 | — | — | US | claimed |
| US-20060063038-A1 | Holographic sensor | CAMBRIDGE ENTERPRISE LTD (GB) | 2006-03-23 | — | — | US | claimed |
| EP-1601999-A1 | HOLOGRAPHIC SENSOR | Smart Holograms Limited (GB) | 2005-12-07 | — | — | EP | claimed |
| WO-2004081624-A1 | HOLOGRAPHIC SENSOR | SMART HOLOGRAMS LIMITED (GB) | 2004-09-23 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12624204-B2 | Ultra-high molecular weight polymers and methods of using the same | MUC1, P4HB, UACA | TGM2 2490/4885PTPN1 357/4885PTPN11 592/4885 |
| US-12279862-B2 | Mediation of in vivo analyte signal degradation | SLC2A1, SLC2A4, SLC2A3 | TGM2 3280/4885PTPN1 781/4885PTPN11 578/4885 |
| US-20240393501-A1 | COATED SILICONE HYDROGEL CONTACT LENSES AND METHOD FOR MAKING THE SAME | CRYAB, P4HB, ILK | TGM2 1576/4885PTPN1 4225/4885PTPN11 4372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.